
The development, SGX says has come as a part of the ongoing arbitration proceedings.
According to SGX, an order dated June 14, 2018 passed by the arbitrator directs SGX and IISL, the National Stock Exchange (NSE)’s index company to facilitate the “continued listing of SGX Nifty products for at least two successive contract month maturations beyond the arbitration’s completion date.”
“SGX was directed to refrain from offering new India equity derivatives products such as those announced on 11 April 2018, in accordance with the order…,” the statement said
As per the statement, arbitration proceedings “are continuing and the hearings on evidence are expected to commence in early 2019”.
